One pill to rule them all? new study tests polypill for heart attack patients

NCT ID NCT07032389

Recruiting now Disease control Sponsor: University of Texas Southwestern Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study tests whether combining three standard heart medications (aspirin, a blood thinner, and a statin) into a single daily pill helps people who've had a heart attack take their medicine more consistently. About 1,000 adults who recently had a heart attack and a stent placed will be randomly assigned to either the polypill or their usual separate pills. The goal is to see if the polypill reduces deaths, blood clots, and bleeding events while improving medication adherence and satisfaction.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute coronary syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE CORONARY SYNDROME

Contacts and locations

Locations

Baylor Scott and White Health System
RECRUITING

Dallas, Texas, 75093, United States
University of Texas Southwestern Medical Center
RECRUITING

Dallas, Texas, 75209, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.